These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11966791)

  • 1. Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing.
    Beeson WH; Rachel JD
    Dermatol Surg; 2002 Apr; 28(4):331-6. PubMed ID: 11966791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of valacyclovir for herpes simplex virus-1 (HSV-1) prophylaxis after facial resurfacing: A randomized clinical trial of dosing regimens.
    Gilbert S; McBurney E
    Dermatol Surg; 2000 Jan; 26(1):50-4. PubMed ID: 10632686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed reactivation of herpes simplex virus infection after facial laser resurfacing.
    Johnson PJ; Hollins RR
    Plast Reconstr Surg; 2000 Sep; 106(3):743-4. PubMed ID: 10987501
    [No Abstract]   [Full Text] [Related]  

  • 4. Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.
    Asbell PA
    Trans Am Ophthalmol Soc; 2000; 98():285-303. PubMed ID: 11190029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
    Miller CS; Cunningham LL; Lindroth JE; Avdiushko SA
    J Am Dent Assoc; 2004 Sep; 135(9):1311-8. PubMed ID: 15493396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
    Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing.
    Alster TS; Nanni CA
    Dermatol Surg; 1999 Mar; 25(3):242-6. PubMed ID: 10193975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1 after experimental reactivation by laser in situ keratomileusis.
    Dhaliwal DK; Romanowski EG; Yates KA; Hu D; Mah FS; Fish DN; Gordon YJ
    J Cataract Refract Surg; 2001 Aug; 27(8):1288-93. PubMed ID: 11524202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK; Baker D; Snowden W
    J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients.
    Warkentin DI; Epstein JB; Campbell LM; Yip JG; Cox VC; Ransier A; Barnett MJ; Marra F
    Ann Pharmacother; 2002 Oct; 36(10):1525-31. PubMed ID: 12243600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
    Dignani MC; Mykietiuk A; Michelet M; Intile D; Mammana L; Desmery P; Milone G; Pavlovsky S
    Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famciclovir as antiviral prophylaxis in laser resurfacing procedures.
    Wall SH; Ramey SJ; Wall F
    Plast Reconstr Surg; 1999 Sep; 104(4):1103-8; discussion 1109. PubMed ID: 10654754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial.
    Aurelius E; Franzen-Röhl E; Glimåker M; Akre O; Grillner L; Jorup-Rönström C; Studahl M;
    Clin Infect Dis; 2012 May; 54(9):1304-13. PubMed ID: 22460966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study.
    Miserocchi E; Modorati G; Galli L; Rama P
    Am J Ophthalmol; 2007 Oct; 144(4):547-51. PubMed ID: 17692271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
    Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
    Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valacyclovir inhibits recovery of ocular HSV-1 after experimental reactivation by excimer laser keratectomy.
    Dhaliwal DK; Romanowski EG; Yates KA; Barnhorst DA; Goldstein M; Deeter RG; Fish DN; Gordon YJ
    Cornea; 1999 Nov; 18(6):693-9. PubMed ID: 10571301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
    Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
    Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.